APO Research
Talk to an analyst

APO RESEARCH · REPORT

Traumatic Brain Injury Diagnostic

Traumatic brain injury (TBI) is a nondegenerative, noncongenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairment of cognitive, physical, and psychosocial functions, with an associated diminished or altered state of consciousness.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Traumatic brain injury (TBI) is a nondegenerative, noncongenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairment of cognitive, physical, and psychosocial functions, with an associated diminished or altered state of consciousness.

Traumatic brain injuries are usually emergencies and consequences can worsen rapidly without treatment. Doctors usually need to assess the situation quickly. Fast acting and effective tests to detect TBI will reduce hospital CT scans (the only current way to diagnose a TBI) by up to a third.

Selected research

Market Analysis & Forecast

Global Traumatic Brain Injury Diagnostic Market Analysis and Forecast 2026-2032

31 December 2025197 pages

Choose your research edition.

Industry ResearchTraumatic Brain Injury Diagnostic Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Traumatic Brain Injury Diagnostic Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Traumatic Brain Injury Diagnostic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Traumatic Brain Injury Diagnostic Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Traumatic Brain Injury Diagnostic Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Traumatic brain injury (TBI) is a nondegenerative, noncongenital insult to the brain from an external mechanical force, possibly leading to permanent or temporary impairment of cognitive, physical, and psychosocial functions, with an associated diminished or altered state of consciousness.

Traumatic brain injuries are usually emergencies and consequences can worsen rapidly without treatment. Doctors usually need to assess the situation quickly. Fast acting and effective tests to detect TBI will reduce hospital CT scans (the only current way to diagnose a TBI) by up to a third.

The major players in global Traumatic Brain Injury Diagnostic market include Banyan Biomarkers, ImPACT Application, BrainScope, etc. The top 3 players occupy about 5% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Instruments is the main type, with a share about 90%. Military Use is the main application, which holds a share about 75%.

Read the full market overview

Report Includes

This report presents an overview of global market for Traumatic Brain Injury Diagnostic, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Traumatic Brain Injury Diagnostic, also provides the revenue of main regions and countries. Of the upcoming market potential for Traumatic Brain Injury Diagnostic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Traumatic Brain Injury Diagnostic revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Traumatic Brain Injury Diagnostic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Traumatic Brain Injury Diagnostic revenue, projected growth trends, production technology, application and end-user industry.

Traumatic Brain Injury Diagnostic Segment by Company

Banyan Biomarkers

ImPACT Application

BrainScope

InfraScan

BrainBox Solution

Quanterix

BioDirection

ABCDx

Oculogica

Traumatic Brain Injury Diagnostic Segment by Type

Consumable

Instruments

Others

Traumatic Brain Injury Diagnostic Segment by Application

Military Use

Civilian Use

Traumatic Brain Injury Diagnostic Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Traumatic Brain Injury Diagnostic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Traumatic Brain Injury Diagnostic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Traumatic Brain Injury Diagnostic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Traumatic Brain Injury Diagnostic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Traumatic Brain Injury Diagnostic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Traumatic Brain Injury Diagnostic revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Traumatic Brain Injury Diagnostic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Consumable Major Player Table 3. Instruments Major Player Table 4. Others Major Player Table 5. Global Traumatic Brain Injury Diagnostic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Military Use Major Player Table 7. Civilian Use Major Player Table 8. Traumatic Brain Injury Diagnostic Industry Trends Table 9. Traumatic Brain Injury Diagnostic Industry Drivers Table 10. Traumatic Brain Injury Diagnostic Industry Opportunities and Challenges Table 11. Traumatic Brain Injury Diagnostic Industry Restraints Table 12. Global Traumatic Brain Injury Diagnostic Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Traumatic Brain Injury Diagnostic Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Traumatic Brain Injury Diagnostic Market Share by Region (2021-2026) Table 15. Global Traumatic Brain Injury Diagnostic Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Traumatic Brain Injury Diagnostic Market Share by Region (2027-2032) Table 17. Global Traumatic Brain Injury Diagnostic Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Players (2021-2026) Table 19. Global Traumatic Brain Injury Diagnostic Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Traumatic Brain Injury Diagnostic Key Players Headquarters & Area Served Table 21. Global Traumatic Brain Injury Diagnostic Players, Product Type & Application Table 22. Global Traumatic Brain Injury Diagnostic Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Traumatic Brain Injury Diagnostic by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Traumatic Brain Injury Diagnostic Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Type (2021-2026) Table 29. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Type (2027-2032) Table 30. Global Traumatic Brain Injury Diagnostic Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Application (2021-2026) Table 34. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Application (2027-2032) Table 35. Banyan Biomarkers Company Information Table 36. Banyan Biomarkers Business Overview Table 37. Banyan Biomarkers Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Banyan Biomarkers Traumatic Brain Injury Diagnostic Product Portfolio Table 39. Banyan Biomarkers Recent Development Table 40. ImPACT Application Company Information Table 41. ImPACT Application Business Overview Table 42. ImPACT Application Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. ImPACT Application Traumatic Brain Injury Diagnostic Product Portfolio Table 44. ImPACT Application Recent Development Table 45. BrainScope Company Information Table 46. BrainScope Business Overview Table 47. BrainScope Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. BrainScope Traumatic Brain Injury Diagnostic Product Portfolio Table 49. BrainScope Recent Development Table 50. InfraScan Company Information Table 51. InfraScan Business Overview Table 52. InfraScan Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. InfraScan Traumatic Brain Injury Diagnostic Product Portfolio Table 54. InfraScan Recent Development Table 55. BrainBox Solution Company Information Table 56. BrainBox Solution Business Overview Table 57. BrainBox Solution Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. BrainBox Solution Traumatic Brain Injury Diagnostic Product Portfolio Table 59. BrainBox Solution Recent Development Table 60. Quanterix Company Information Table 61. Quanterix Business Overview Table 62. Quanterix Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Quanterix Traumatic Brain Injury Diagnostic Product Portfolio Table 64. Quanterix Recent Development Table 65. BioDirection Company Information Table 66. BioDirection Business Overview Table 67. BioDirection Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. BioDirection Traumatic Brain Injury Diagnostic Product Portfolio Table 69. BioDirection Recent Development Table 70. ABCDx Company Information Table 71. ABCDx Business Overview Table 72. ABCDx Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. ABCDx Traumatic Brain Injury Diagnostic Product Portfolio Table 74. ABCDx Recent Development Table 75. Oculogica Company Information Table 76. Oculogica Business Overview Table 77. Oculogica Traumatic Brain Injury Diagnostic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Oculogica Traumatic Brain Injury Diagnostic Product Portfolio Table 79. Oculogica Recent Development Table 80. North America Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Traumatic Brain Injury Diagnostic Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Traumatic Brain Injury Diagnostic Revenue by Country (US$ Million) & (2027-2032) Table 94. China Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 95. China Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 96. China Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 97. China Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Traumatic Brain Injury Diagnostic Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Traumatic Brain Injury Diagnostic Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Traumatic Brain Injury Diagnostic Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Traumatic Brain Injury Diagnostic Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Traumatic Brain Injury Diagnostic Image Figure 2. Global Traumatic Brain Injury Diagnostic Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Traumatic Brain Injury Diagnostic Market Size Share 2021 VS 2025 VS 2032 Figure 4. Consumable Image Figure 5. Instruments Image Figure 6. Others Image Figure 7. Global Traumatic Brain Injury Diagnostic Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Traumatic Brain Injury Diagnostic Market Size Share 2021 VS 2025 VS 2032 Figure 9. Military Use Image Figure 10. Civilian Use Image Figure 11. Global Traumatic Brain Injury Diagnostic Market Size (US$ Million) & (2021-2032) Figure 12. Global Traumatic Brain Injury Diagnostic Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Traumatic Brain Injury Diagnostic Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Traumatic Brain Injury Diagnostic Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Traumatic Brain Injury Diagnostic Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Traumatic Brain Injury Diagnostic Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Type (2021-2032) Figure 19. Global Traumatic Brain Injury Diagnostic Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Traumatic Brain Injury Diagnostic Revenue Market Share by Application (2021-2032) Figure 22. North America Traumatic Brain Injury Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032) Figure 24. North America Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032) Figure 25. North America Traumatic Brain Injury Diagnostic Revenue Share by Country (2021-2032) Figure 26. United States Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Traumatic Brain Injury Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032) Figure 31. Europe Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032) Figure 32. Europe Traumatic Brain Injury Diagnostic Revenue Share by Country (2021-2032) Figure 33. Germany Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Traumatic Brain Injury Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032) Figure 43. China Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032) Figure 44. Asia Traumatic Brain Injury Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032) Figure 46. Asia Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032) Figure 47. Asia Traumatic Brain Injury Diagnostic Revenue Share by Region (2021-2032) Figure 48. Japan Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Traumatic Brain Injury Diagnostic Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032) Figure 56. SAMEA Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032) Figure 57. SAMEA Traumatic Brain Injury Diagnostic Revenue Share by Country (2021-2032) Figure 58. Brazil Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Traumatic Brain Injury Diagnostic Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Consumable
  • Instruments
  • Others
Applications
  • Military Use
  • Civilian Use
Companies covered
  • Banyan Biomarkers
  • ImPACT Application
  • BrainScope
  • InfraScan
  • BrainBox Solution
  • Quanterix
  • BioDirection
  • ABCDx
  • Oculogica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Traumatic Brain Injury Diagnostic Market by Type
  3. 1.2.1 Global Traumatic Brain Injury Diagnostic Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Consumable
  5. 1.2.3 Instruments
  6. 1.2.4 Others
  7. 1.3 Traumatic Brain Injury Diagnostic Market by Application
  8. 1.3.1 Global Traumatic Brain Injury Diagnostic Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Military Use
  10. 1.3.3 Civilian Use
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Traumatic Brain Injury Diagnostic Market Dynamics
  1. 2.1 Traumatic Brain Injury Diagnostic Industry Trends
  2. 2.2 Traumatic Brain Injury Diagnostic Industry Drivers
  3. 2.3 Traumatic Brain Injury Diagnostic Industry Opportunities and Challenges
  4. 2.4 Traumatic Brain Injury Diagnostic Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Traumatic Brain Injury Diagnostic Market Perspective (2021-2032)
  2. 3.2 Global Traumatic Brain Injury Diagnostic Growth Trends by Region
  3. 3.2.1 Global Traumatic Brain Injury Diagnostic Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Traumatic Brain Injury Diagnostic Market Size by Region (2021-2026)
  5. 3.2.3 Global Traumatic Brain Injury Diagnostic Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Traumatic Brain Injury Diagnostic Revenue by Players
  2. 4.1.1 Global Traumatic Brain Injury Diagnostic Revenue by Players (2021-2026)
  3. 4.1.2 Global Traumatic Brain Injury Diagnostic Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Traumatic Brain Injury Diagnostic Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Traumatic Brain Injury Diagnostic Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Traumatic Brain Injury Diagnostic Key Players Headquarters & Area Served
  7. 4.4 Global Traumatic Brain Injury Diagnostic Players, Product Type & Application
  8. 4.5 Global Traumatic Brain Injury Diagnostic Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Traumatic Brain Injury Diagnostic Market CR5 and HHI
  11. 4.6.3 2025 Traumatic Brain Injury Diagnostic Tier 1, Tier 2, and Tier 3
5 Traumatic Brain Injury Diagnostic Market Size by Type
  1. 5.1 Global Traumatic Brain Injury Diagnostic Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Traumatic Brain Injury Diagnostic Revenue by Type (2021-2032)
  3. 5.3 Global Traumatic Brain Injury Diagnostic Revenue Market Share by Type (2021-2032)
6 Traumatic Brain Injury Diagnostic Market Size by Application
  1. 6.1 Global Traumatic Brain Injury Diagnostic Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Traumatic Brain Injury Diagnostic Revenue by Application (2021-2032)
  3. 6.3 Global Traumatic Brain Injury Diagnostic Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Banyan Biomarkers
  2. 7.1.1 Banyan Biomarkers Company Information
  3. 7.1.2 Banyan Biomarkers Business Overview
  4. 7.1.3 Banyan Biomarkers Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Banyan Biomarkers Traumatic Brain Injury Diagnostic Product Portfolio
  6. 7.1.5 Banyan Biomarkers Recent Developments
  7. 7.2 ImPACT Application
  8. 7.2.1 ImPACT Application Company Information
  9. 7.2.2 ImPACT Application Business Overview
  10. 7.2.3 ImPACT Application Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  11. 7.2.4 ImPACT Application Traumatic Brain Injury Diagnostic Product Portfolio
  12. 7.2.5 ImPACT Application Recent Developments
  13. 7.3 BrainScope
  14. 7.3.1 BrainScope Company Information
  15. 7.3.2 BrainScope Business Overview
  16. 7.3.3 BrainScope Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BrainScope Traumatic Brain Injury Diagnostic Product Portfolio
  18. 7.3.5 BrainScope Recent Developments
  19. 7.4 InfraScan
  20. 7.4.1 InfraScan Company Information
  21. 7.4.2 InfraScan Business Overview
  22. 7.4.3 InfraScan Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  23. 7.4.4 InfraScan Traumatic Brain Injury Diagnostic Product Portfolio
  24. 7.4.5 InfraScan Recent Developments
  25. 7.5 BrainBox Solution
  26. 7.5.1 BrainBox Solution Company Information
  27. 7.5.2 BrainBox Solution Business Overview
  28. 7.5.3 BrainBox Solution Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BrainBox Solution Traumatic Brain Injury Diagnostic Product Portfolio
  30. 7.5.5 BrainBox Solution Recent Developments
  31. 7.6 Quanterix
  32. 7.6.1 Quanterix Company Information
  33. 7.6.2 Quanterix Business Overview
  34. 7.6.3 Quanterix Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Quanterix Traumatic Brain Injury Diagnostic Product Portfolio
  36. 7.6.5 Quanterix Recent Developments
  37. 7.7 BioDirection
  38. 7.7.1 BioDirection Company Information
  39. 7.7.2 BioDirection Business Overview
  40. 7.7.3 BioDirection Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  41. 7.7.4 BioDirection Traumatic Brain Injury Diagnostic Product Portfolio
  42. 7.7.5 BioDirection Recent Developments
  43. 7.8 ABCDx
  44. 7.8.1 ABCDx Company Information
  45. 7.8.2 ABCDx Business Overview
  46. 7.8.3 ABCDx Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  47. 7.8.4 ABCDx Traumatic Brain Injury Diagnostic Product Portfolio
  48. 7.8.5 ABCDx Recent Developments
  49. 7.9 Oculogica
  50. 7.9.1 Oculogica Company Information
  51. 7.9.2 Oculogica Business Overview
  52. 7.9.3 Oculogica Traumatic Brain Injury Diagnostic Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Oculogica Traumatic Brain Injury Diagnostic Product Portfolio
  54. 7.9.5 Oculogica Recent Developments
8 North America
  1. 8.1 North America Traumatic Brain Injury Diagnostic Revenue (2021-2032)
  2. 8.2 North America Traumatic Brain Injury Diagnostic Revenue by Type (2021-2032)
  3. 8.2.1 North America Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026)
  4. 8.2.2 North America Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032)
  5. 8.3 North America Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032)
  6. 8.4 North America Traumatic Brain Injury Diagnostic Revenue by Application (2021-2032)
  7. 8.4.1 North America Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026)
  8. 8.4.2 North America Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032)
  9. 8.5 North America Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032)
  10. 8.6 North America Traumatic Brain Injury Diagnostic Revenue by Country
  11. 8.6.1 North America Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026)
  13. 8.6.3 North America Traumatic Brain Injury Diagnostic Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Traumatic Brain Injury Diagnostic Revenue (2021-2032)
  2. 9.2 Europe Traumatic Brain Injury Diagnostic Revenue by Type (2021-2032)
  3. 9.2.1 Europe Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026)
  4. 9.2.2 Europe Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032)
  5. 9.3 Europe Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032)
  6. 9.4 Europe Traumatic Brain Injury Diagnostic Revenue by Application (2021-2032)
  7. 9.4.1 Europe Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026)
  8. 9.4.2 Europe Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032)
  9. 9.5 Europe Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032)
  10. 9.6 Europe Traumatic Brain Injury Diagnostic Revenue by Country
  11. 9.6.1 Europe Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026)
  13. 9.6.3 Europe Traumatic Brain Injury Diagnostic Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Traumatic Brain Injury Diagnostic Revenue (2021-2032)
  2. 10.2 China Traumatic Brain Injury Diagnostic Revenue by Type (2021-2032)
  3. 10.2.1 China Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026)
  4. 10.2.2 China Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032)
  5. 10.3 China Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032)
  6. 10.4 China Traumatic Brain Injury Diagnostic Revenue by Application (2021-2032)
  7. 10.4.1 China Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026)
  8. 10.4.2 China Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032)
  9. 10.5 China Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Traumatic Brain Injury Diagnostic Revenue (2021-2032)
  2. 11.2 Asia Traumatic Brain Injury Diagnostic Revenue by Type (2021-2032)
  3. 11.2.1 Asia Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026)
  4. 11.2.2 Asia Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032)
  5. 11.3 Asia Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032)
  6. 11.4 Asia Traumatic Brain Injury Diagnostic Revenue by Application (2021-2032)
  7. 11.4.1 Asia Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026)
  8. 11.4.2 Asia Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032)
  9. 11.5 Asia Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032)
  10. 11.6 Asia Traumatic Brain Injury Diagnostic Revenue by Country
  11. 11.6.1 Asia Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026)
  13. 11.6.3 Asia Traumatic Brain Injury Diagnostic Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Traumatic Brain Injury Diagnostic Revenue (2021-2032)
  2. 12.2 SAMEA Traumatic Brain Injury Diagnostic Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Traumatic Brain Injury Diagnostic Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Traumatic Brain Injury Diagnostic Revenue by Type (2027-2032)
  5. 12.3 SAMEA Traumatic Brain Injury Diagnostic Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Traumatic Brain Injury Diagnostic Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Traumatic Brain Injury Diagnostic Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Traumatic Brain Injury Diagnostic Revenue by Application (2027-2032)
  9. 12.5 SAMEA Traumatic Brain Injury Diagnostic Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Traumatic Brain Injury Diagnostic Revenue by Country
  11. 12.6.1 SAMEA Traumatic Brain Injury Diagnostic Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Traumatic Brain Injury Diagnostic Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Traumatic Brain Injury Diagnostic Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst